Health Technology Holding
Milan, Lombardyhthvc.com
Overview
Health Technology Holding (HTH) is a Milan-based venture capital firm founded in 2020, operating as part of ZCube-Zambon Research Venture. The firm is an active, hands-on investor focusing on early to mid-stage companies with breakthrough technologies in the Life Sciences sector. Its investment areas include Medtech, Biotech, Digital Health, Femtech, diagnostics, and consumer healthcare, with a global geographic focus on Europe, the USA, Canada, and Israel.
Portfolio Companies
9
Website
hthvc.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Lys Therapeutics | Jun 2026 | Financing | Co-investor |
| EpilepsyGTx | Jun 2024 | Seed | Co-investor |
| SensArs Neuroprosthetics | May 2024 | Pre Seed | Lead |
| Leuko Labs | Sep 2022 | Series A | Lead |
| Neurofenix | Aug 2022 | Series A | Co-investor |
Key People
Michele Gaiotto
Managing Principal
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
